Biotechnology: Acquisition of a company with Greek roots for $1.7 billion
Regulus Therapeutics, a California-based biotechnology company with deep Greek roots, is acquired by Novartis
Pharmaceutical industry spring summit: Greece at the heart of pharmaceutical innovation
The Prime Minister's meeting with the CEOs of the world's largest industries in the sector marks the beginning of a new era that will upgrade our country, attracting billions in investment. Huge potential for growth in biotechnology, pharmaceutical manufacturing, digital health, clinical trials and biopharmaceutical services for the benefit of the national economy and citizens
